Drug Development: Looking for Effective Combinations
My work with reformulating the anticancer drug vincristine led to a pivotal moment in my training and development as a scientist at the BC …
Philanthropy and Research
Ovarian Cancer Research: Three Major Milestones and a Look at the Future
Today, I’d like to share three major things that B.C.’s OVCARE team has contributed in the last decade: 1) TAKING STEPS TOWARD PERSONALIZED MEDICINE: A …
Philanthropy and Research: How Donors are Making a Difference
In my last two blog posts, I wrote about progress we’ve been making to improve outcomes for women facing endometrial cancer. Today, I’d like …
Bench to Bedside: How Research Discoveries are Leading to Solutions for Gynecologic Cancers
A nice thing about being junior in your career is that sometimes if you work hard, think a bit, and play well with others, …
Final Thoughts on the Future of Pancreatic Cancer Research
At Pancreas Cancer BC, we are very interested in understanding what cellular and molecular changes initially lead to cancerous changes, and also how the …
Personalized Therapy for Pancreatic Cancer
In my last several posts I discussed some of the new treatments being developed for pancreatic cancer. As more options become available it is …
Challenges in the Present, Hope for the Future
Cancer has proven itself as a difficult disease to cure. With the continued support of BC Cancer Foundation donors, the BC Cancer Agency will …
How B.C. Donors Support Cancer Research and Innovations to Care
The collaboration and partnership of the BC Cancer Foundation with the BC Cancer Agency is of great value to our patients and all British …
Introducing February Guest Blogger Dr. Maha Almahmudi
I’d like to start by thanking our January guest blogger, Dr. Randy Gascoyne, for highlighting how generous donor support is fueling advancements in lymphoid …
Instrumental Support: Donors Making a Difference for Lymphoid Cancer Research
The BC Cancer Foundation provides instrumental support to the Gascoyne Laboratory and a number of other researchers within the Centre for Lymphoid Cancer (CLC) …